Robert George Boyle

This inventor holds 24 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Sentinel Oncology Limited, Astex Therapeutics Limited, Cancer Research Technology Limited. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert George Boyle. Retrieved from https://idiyas.com/inventor/robert-george-boyle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 4)

% Patents Active = 62.5

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 13 (Patent Applications = 16)

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 73(Granted Patents)

Company Filing History:

12 out of 12

Sentinel Oncology Limited

patents

9 out of 126

Astex Therapeutics Limited

patents

9 out of 269

Cancer Research Technology Limited

patents

4. 9 out of 54

The Institute of Cancer Research: Royal Cancer Hospital

patents

5. 1 out of 1

Cascadian Therapeutics, Inc.

patent

6. 1 out of 129

Dainippon Pharmaceutical Company, Limited

patents

7. 1 out of 855

Millennium Pharmaceuticals Limited

patents

where one patent can have more than one assignee

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

Pyrrole Derivatives

Protein Kinase Inhibitors

Pharmaceutical Compounds

Pyrazole Derivatives

Chymase Inhibitors

P70S6 Kinase

Brain Disorders

Triple-Negative Breast Cancer

Purine Derivatives

Benzotriazines

Quinoxalines

Pharmaceutical Combinations

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12637424 - Pharmaceutical salt of an arylpyrrole derivative (2026-05-26),

2. 11884656 - Pyrrole derivatives as PLK1 inhibitors (2024-01-30),

3. 11786524 - Pharmaceutical compounds (2023-10-17),

4. 11208405 - Pyrrole derivatives as PLK1 inhibitors (2021-12-28),

5. 10973817 - Pharmaceutical compounds (2021-04-13),

6. 10730882 - 2-aminoquinazoline derivatives as P70S6 kinase inhibitors (2020-08-04),

7. 10344033 - 2-aminoquinazoline derivatives as P70S6 kinase inhibitors (2019-07-09),

8. 10144726 - Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer (2018-12-04),

9. 10010547 - Pharmaceutical compounds (2018-07-03),

10. 9630931 - Pharmaceutically active pyrazine derivatives (2017-04-25),

11. 9283226 - Pyrazole derivatives as protein kinase modulators (2016-03-15),

12. 9006430 - Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein (2015-04-14),

13. 8809336 - Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors (2014-08-19),

14. 8796293 - Purine and deazapurine derivatives as pharmaceutical compounds (2014-08-05),

15. 8716473 - Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase (2014-05-06),

Title: Robert George Boyle - Innovator from Cambridge, GB

Introduction: Robert George Boyle is a renowned inventor hailing from Cambridge, GB, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Robert George Boyle holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over two decades, Boyle has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized their respective industries.

Collaborations: Throughout his career, Robert George Boyle has collaborated with top companies, patent attorneys, and fellow inventors to bring his ideas to life and secure his innovations through the patenting process.

Conclusion: Robert George Boyle's passion for innovation and his dedication to pushing the boundaries of technology make him a standout figure in the world of inventors, with a legacy that will continue to inspire future generations of innovators.

Profile summary based on public USPTO records.